Top Markets
Coin of the day
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Rank in Stocks #29434
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$3.92
Last synced: 2026-07-31
Market Cap
$21.16M
Change (1 day)
-0.13%
Change (1 year)
-48.76%
Country
US
Trade Neuphoria Therapeutics Inc. (NEUP)

Category

Operating Margin for Neuphoria Therapeutics Inc. (NEUP)
Operating Margin as of 2026 TTM: 0.00%
According to Neuphoria Therapeutics Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Neuphoria Therapeutics Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.